• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Reserpine Tablets

 Status: Currently in Shortage

 » Date first posted: 04/17/2013
 » Therapeutic Categories: Cardiovascular; Pediatric

Sandoz (Revised 07/20/2015)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.25 mg 100s (NDC 0185-0134-01) Currently unavailable, estimated recovery will be Feb 2016. API and Raw Material changes required, changes currently in process API and Raw Material changes. required, changes currently in process
0.25 mg 1000s (NDC 0185-0134-10) Currently unavailable, estimated recovery will be Feb 2016. API and Raw Material changes required, changes currently in process API and Raw Material changes. required, changes currently in process
0.1 mg 100s (NDC 0185-0032-01) Currently unavailable, estimated recovery will be Aug/Sept 2015 (0.1 mg) and Jan 2016 (0.25 mg). API and Raw Material changes required, changes currently in process API and Raw Material changes. required, changes currently in process
0.1 mg 1000s (NDC 0185-0032-10) Currently unavailable, estimated recovery will be Aug/Sept 2015 (0.1 mg) and Jan 2016 (0.25 mg). API and Raw Material changes required, changes currently in process API and Raw Material changes. required, changes currently in process
-
-